Lisinopril

This classification denotes an ace inhibitor with the molecular formula C21H31N3O5.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7199S1YWR, chemically known as l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-, dihydrate, (s)- but generally known as lisinopril, which bears US NIH Compound Identifier 5362118. European Medicines Agency schedules Lisinopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08533MIG. World Health Organization schedules lisinopril in its Anatomical Therapeutic Chemical (ATC) Classification. LISINOPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lisinopril under HS 29339990 and SITC 51577. As of Q4 2014, LISINOPRIL remains the US FDA Preferred Term for this commodity. Lisinopril bears US NLM identifiers UMLS ID C0065374 and NCI Concept Code C29159. SMILES: O=C(N1C(CCC1)C(=O)O)C(NC(CCc1ccccc1)C(=O)O)CCCCN.O.O.